Patent Assignment
Reel/Frame 019936/0807
Other Transfer of Rights by Corporate Dissolution
Recorded: 2007-10-05
Pages: 9
Assignor
BIOVAIL LABORATORIES (2005) INC.
Executed: 2005-01-28
Assignee
BIOVAIL LABORATORIES INTERNATIONAL SRL
BUILDING NO. 2, CHELSTON PARK, COLLYMORE ROCK, ST. MICHAEL, BARBADOS
Covered Properties
(7)
Sedative non-benzodiazepine formulations
Application:
10/338,876 →
Publication:
US 2003/0165566
Controlled Release Dosage Forms
Modified release formulations of at least one form of tramadol
Application:
10/434,266 →
Publication:
US 2004/0224949
Modified-release tablet of bupropion hydrochloride
Application:
10/507,525 →
Publication:
US 2005/0238718
Modified Release Compositions of at Least One Form of Tramadol
Patent:
8,128,957 →
Application:
10/933,479 →
Chronotherapeutic diltiazem formulations and the administration thereof
Application:
11/370,842 →
Publication:
US 2006/0153914
Modified Release Tablet of Bupropion Hydrochloride
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 11, 2003
From: O'TOOLE, EDEL; FOGARTY, SIOBHAN
To: BIOVAIL LABORATORIES INC.
Reel/Frame 014264/0021 →
Assignment of Assignor's Interest
Oct 9, 2003
From: ZHOU, FANG; MAES, PAUL
To: BIOVAIL LABORATORIES, INC.
Reel/Frame 014583/0485 →
Assignment of Assignor's Interest
Nov 30, 2004
From: SETH, PAWAN; MAES, PAUL
To: BIOVAIL LABORATORIES, INC.
Reel/Frame 016030/0937 →
Assignment of Assignor's Interest
Jul 14, 2005
From: SETH, PAWAN; MAES, PAUL J.
To: BIOVAIL LABORATORIES
Reel/Frame 016740/0388 →
Assignment of Assignor's Interest
Mar 13, 2006
From: ZHOU, FANG; MAES, PAUL
To: BIOVAIL LABORATORIES INC.
Reel/Frame 017665/0563 →
Merger
Oct 5, 2007
From: BIOVAIL LABORATORIES INCORPORATED
To: BIOVAIL LABORATORIES (2005) INC.
Reel/Frame 019936/0816 →
Patent and Trademark Security Agreement
Jun 11, 2009
From: BIOVAIL LABORATORIES INTERNATIONAL SRL
To: J.P. MORGAN CHASE BANK, N.A., TORONTO BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 022813/0195 →
Security Agreement
Oct 4, 2010
From: BIOVAIL INTERNATIONAL LABORATORIES SRL; BIOVAIL INTERNATIONAL LABORATORIES (BARBADOS) SRL
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0022 →
Release of Security Agreement
Oct 6, 2010
From: JPMORGAN CHASE BANK, N.A., TORONTO BRANCH
To: BIOVAIL CORPORATION; BIOVAIL LABORATORIES INTERNATIONAL SRL
Reel/Frame 025095/0479 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: BIOVAIL INTERNATIONAL LABORATORIES SRL; BIOVAIL INTERNATIONAL LABORATORIES (BARBADOS) SRL
Reel/Frame 025950/0073 →
Change of Name
Jun 2, 2011
From: BIOVAIL LABORATORIES INTERNATIONAL SRL
To: VALEANT INTERNATIONAL (BARBADOS) SRL
Reel/Frame 026375/0312 →
Change of Name
Jun 7, 2011
From: BIOVAIL LABORATORIES INTERNATIONAL SRL
To: VALEANT INTERNATIONAL (BARBADOS) SRL
Reel/Frame 026404/0095 →
Security Agreement
Jul 18, 2011
From: VALEANT INTERNATIONAL (BARBADOS) SRL, A BARBADOS INTERNATIONAL SOCIETY WITH RESTRICTED LIABILITY; BIOVALE LABORATORIES INTERNATIONAL (BARBADOS) SRL, A BARBADOS INTERNATIONAL SOCIETY WITH RESTRICTED LIABILITY
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 026605/0801 →
Change in Name and Country of Incorporation
Aug 9, 2012
From: VALEANT INTERNATIONAL (BARBADOS) SRL
To: VALEANT INTERNATIONAL BERMUDA
Reel/Frame 028757/0052 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Assignment of Assignor's Interest
Jan 20, 2016
From: VALEANT HOLDINGS IRELAND
To: VALEANT HOLDINGS IRELAND, LUXEMBOURG BRANCH
Reel/Frame 037529/0212 →
Assignment of Assignor's Interest
Jan 20, 2016
From: VALEANT INTERNATIONAL BERMUDA
To: VALEANT HOLDINGS IRELAND
Reel/Frame 037529/0057 →
Assignment of Assignor's Interest
Jan 20, 2016
From: VALEANT HOLDINGS IRELAND, LUXEMBOURG BRANCH
To: VALEANT PHARMACEUTICALS LUXEMBOURG S.Á.R.L.
Reel/Frame 037529/0357 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Merger
Apr 19, 2019
From: VALEANT INTERNATIONAL BERMUDA
To: VALEANT HOLDINGS IRELAND
Reel/Frame 048939/0764 →
Assignment of Assignor's Interest
Apr 22, 2019
From: VALEANT HOLDINGS IRELAND
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 048954/0900 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Assignment of Assignor's Interest
Oct 24, 2019
From: VALEANT PHARMACEUTICALS LUXEMBOURG S.Á.R.L.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 050817/0312 →
Security Interest
Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →